Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene

Ann Neurol. 2000 Apr;47(4):517-20.

Abstract

Although it is assumed that most patients with autosomal dominant dopa-responsive dystonia (DRD) have a GTP cyclohydrolase I dysfunction, conventional genomic DNA sequencing of the gene (GCH1) coding for this enzyme fails to reveal any mutations in about 40% of DRD patients, which makes molecular genetic diagnosis difficult. We found a large heterozygous GCH1 deletion, which cannot be detected by the usual genomic DNA sequence analysis, in a three-generation DRD family and conclude that a large genomic deletion in GCH1 may account for some "mutation-negative" patients with dominantly inherited DRD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blotting, Southern
  • DNA Mutational Analysis
  • DNA, Complementary
  • Dopamine Agents / administration & dosage
  • Dystonia / drug therapy
  • Dystonia / enzymology*
  • Dystonia / genetics*
  • Family Health
  • Female
  • GTP Cyclohydrolase / genetics*
  • Gene Deletion*
  • Humans
  • Levodopa / administration & dosage
  • Male
  • Middle Aged
  • Pedigree

Substances

  • DNA, Complementary
  • Dopamine Agents
  • Levodopa
  • GTP Cyclohydrolase